(Reuters) – The U.S. government has ordered another 2.5 million doses of Bavarian Nordic’s vaccine for use against monkeypox, the Danish vaccine maker said on Friday.
The vaccine, Jynneos, is cleared in the United States for the prevention of smallpox and monkeypox disease among adults.
The United States had ordered 500,000 doses of the vaccine in June, followed by another 2.5 million earlier this month, as it ramps up its fight against a global outbreak of the viral disease which causes flu-like symptoms and skin lesions.
Around 60 countries in which monkeypox is not endemic have reported outbreaks of the viral disease, with confirmed cases crossing 11,500.
(Reporting by Amruta Khandekar; Editing by Devika Syamnath)
